As COVID-19 enters its fourth season, the United States is grappling with a concerning rise in hospital admissions, emergency department visits, and positive tests, according to recent data from the Centers for Disease Control and Prevention (CDC).
The emergence of the latest Omicron subvariant, EG.5, has further exacerbated the situation, accounting for a staggering 17.5% of all new cases nationally.
Covid-19: Emergence of Omicron Subvariant EG.5
This particular subvariant has rapidly gained ground, more than doubling its prevalence in less than a month.
Health officials are concerned about EG.5’s rapid dissemination despite its symptoms being similar to those of earlier versions.
The World Health Organization (WHO) noted its similarity to past variants, signaling the persistence of a familiar threat.
Amidst these developments, COVID-19-related hospital admissions have experienced a notable increase across the country, with the national average surging by 12.5% in the past week.
However, certain areas, like Humboldt County in Nevada, are witnessing even higher spikes, where hospital admissions escalated by 26.7% within the same period.
Nevada, as a whole, is navigating a complex landscape of COVID-19 metrics.
Counties such as Mineral, Lyon, Storey, and Washoe are encountering significant changes in hospital admissions.
On the other hand, southern counties like Clark County have managed to achieve a drop of -7.7% in hospital admissions, offering a glimmer of hope.
Positive test rates and emergency department visits, while indicating a relatively better scenario compared to neighboring states like California, Idaho, and Utah, do not provide a comprehensive picture as they don’t account for at-home tests.
Amidst this evolving situation, health officials are outlining plans to shift the Covid-19 vaccination program from federal oversight to the commercial market.
Read more: Carcinogens Found In Montana Nuclear Sites Linked To Cancer Outbreak
Transitioning Vaccination Programs
The US Department of Health and Human Services (HHS) has revealed intentions to end the federal government’s vaccination program this month, with commercialization set to commence as early as September.
This transition will undoubtedly impact the millions of American adults without insurance, as well as those whose insurance policies do not offer free coverage for vaccines.
To address this potential gap in access, the CDC and HHS are launching the “Bridge Access Program For COVID-19 Vaccines and Treatments.”
This initiative aims to ensure that the uninsured population continues to have access to vaccines and treatments by facilitating partnerships with local health departments and pharmacy chains.
This strategy involves purchasing vaccines directly from manufacturers and making them available to those without insurance.
As the nation grapples with a resurgence in COVID-19 cases, these developments underscore the critical need for a comprehensive and flexible approach to both managing the ongoing crisis and ensuring equitable access to essential healthcare resources.
Read more: US Study Highlights Breast Cancer Overdiagnosis Risk For Women In Their 70s
